Assessment of HPV detection assays for use in cervical cancer screening programs;Evaluación de las técnicas de detección del VPH en los programas de cribado para cáncer de cuello uterino

Salud Publica de Mexico

Volumn 48, Issue 5, 2006, Pages 373-378

  Cañadas, M Paz ^a   Lloveras, Belén ^b   Lorincz, Attila ^c   Ejarque, Maijo ^a   Font, Rebeca ^b   Bosch, F Xavier ^b   De Sanjosé, Silvia ^b  

^a General Lab   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c Digene Corporation   (United States)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Espa a; Human papillomavirus; Hybridization; PCR

Indexed keywords

ARTICLE; CANCER SCREENING; CELL HYBRIDIZATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SPAIN; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

DNA PROBES, HPV; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 33750340641     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Walboomers IMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
2. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses. JAMA 1989;262:931-934.
3. National Cancer Institute Workshop. The revised Bethesda system for reporting cervical/vaginal diagnoses. JAMA 1992;267:1892.
4. Sherman ME, Schiffman MH, Lorincz AT, Manos MM, Scott DR, Kurman RJ, et al. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994;102:182-187.
5. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610.
6. Solomon D, Schiffman M, Tarone R. ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
7. Canadas MP, Martinez F, Sanjose S, Valls I, Lloveras B, Bosch FX, et al. Detection of human papillomavirus DNA by PCR in high-risk women. Validation of a protocol. Enferm Infecc Microbiol Clin 1998;16:400-403.
8. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-3027.
9. Cox JT. Evaluating the role of VPH testing for women with equivocal Papanicoalou test findings (editorial). JAMA 1999;281:1645-1647.
10. Ho L, Terry G, Londesborough P, Cuzick J, Lorenzato F, Singer A. Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears. J Med Virol 2003;69:118-121.
11. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-361.
12. Fuessel AL, He Q, Rady PL, et al. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 2004;122(1):87-89.
13. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37(8):2508-2517.
14. Ponten J, Guo Z. Precancer of the human cervix. Cancer Surv 1998;32:201-229.
15. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al. Type'specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-1638.
16. Soderlund-Strand A, Rymark P, Andersson P, Dillner J, Dillner L. Comparison between the hybrid capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J Clin Microbiol 2005;43(7):3260-3266.